Thursday, October 01, 2020 1:05:18 AM
So here we are about 6 wks later with most ( or at least myself ) expecting Dr Javitt to announce the trial was full enrolled and the interim report for the 102 patients was such as such ....and what did we get ?
That's what caused this sell off.
IMHO there is no way the FDA will authorize an EUA until they have at least seen the interim data on these 102 patients ...and that's not for 28 days at the earliest
So now its a different risk profile investment ...I sold half my position .
Good luck
Kiwi
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM